Not logged in CD8+Tcells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer Napolitano, Fabiana; Wang, Yunguan; Sudhan, Dhivya R.; Gonzalez-Ericsson, Paula I.; Formisano, Luigi; Unni, Nisha; Shakeel, Shahbano; Zhu, James Z.; Ahuja, Khushi; Guo, Lei; Chica-Parrado, Maria Rosario; Matsunaga, Yuki; Luna, Pamela; Lin, Chang-Ching A.; Uemoto, Yasuaki; Lee, Kyung-Min; Ma, Hongli; Evans, Nathaniel J.; Servetto, Alberto; Mendiratta, Saurabh; Barnes, Spencer D.; Bianco, Roberto; V. Fang, Yisheng; Xu, Lin; Lee, Jeon; Wang, Tao; Balko, Justin M.; Mills, Gordon B.; Labrie, Marilyne; Hanker, Ariella B.; Arteaga, Carlos L. Share Save
Corrigendum to “Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer” [604 (2024) 217219 1–12] Chica-Parrado, Maria Rosario; Kim, Gun Min; Uemoto, Yasuaki; Napolitano, Fabiana; Lin, Chang-Ching; Ye, Dan; Bikorimana, Emmanuel; Fang, Yisheng; Lee, Kyung-min; Mendiratta, Saurabh; Hanker, Ariella B.; Arteaga, Carlos L. Share Save
Share Save
Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations (vol 619, 217668, 2025) Uemoto, Yasuaki; Lin, Chang-Ching A.; Wang, Bingnan; Ye, Dan; Fang, Yisheng, V; Bikorimana, Emmanuel; Napolitano, Fabiana; Chica-Parrado, Maria Rosario; Li, Cheung; Mendiratta, Saurabh; Chen, Chuo; Hanker, Ariella B.; Arteaga, Carlos L. Share Save
Share Save
Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer Chica-Parrado, Maria Rosario; Kim, Gun Min; Uemoto, Yasuaki; Napolitano, Fabiana; Lin, Chang-Ching; Ye, Dan; Bikorimana, Emmanuel; Fang, Yisheng; Lee, Kyung-min; Mendiratta, Saurabh; Hanker, Ariella B.; Arteaga, Carlos L. Share Save
Mapping cellular interactions from spatially resolved transcriptomics data Zhu, James; Wang, Yunguan; Chang, Woo Yong; Malewska, Alicia; Napolitano, Fabiana; Gahan, Jeffrey C.; Unni, Nisha; Zhao, Min; Yuan, Rongqing; Wu, Fangjiang; Yue, Lauren; Guo, Lei; Zhao, Zhuo; Chen, Danny Z.; Hannan, Raquibul; Zhang, Siyuan; Xiao, Guanghua; Mu, Ping; Hanker, Ariella B.; Strand, Douglas; Arteaga, Carlos L.; Desai, Neil; Wang, Xinlei; Xie, Yang; Wang, Tao Share Save
Evaluating the immunologically cold tumor microenvironment after treatment with immune checkpoint inhibitors utilizing PET imaging of CD4+and CD8+T cells in breast cancer mouse models Lu, Yun; Houson, Hailey A.; Gallegos, Carlos A.; Mascioni, Alessandro; Jia, Fang; Aivazian, Argin; Song, Patrick N.; Lynch, Shannon E.; Napier, Tiara S.; Mansur, Ameer; Larimer, Benjamin M.; Lapi, Suzanne E.; Hanker, Ariella B.; Sorace, Anna G. Share Save
A bedside-to-bench translational analysis demonstrates that NF1 alterations promote CDK4/6 inhibitor (CDK4/6i) resistance in hormone receptor-positive (HR plus ) metastatic breast cancer (MBC) Lloyd, Maxwell; Chica-Parrado, M. Rosario; Knepper, Todd; Lin, Chang-Ching; Podany, Emily; Walko, Christine; Napolitano, Fabiana; Weipert, Caroline; Liao, Jiemin; Medford, Arielle; Ryan, Lianne; Keenan, Jennifer; Zhang, Nicole; Liu, Shiyuan; Wulf, Gerburg; Clifton, Katherine; Ma, Cynthia; Han, Hyo; Ellisen, Leif; Bardia, Aditya; Arteaga, Carlos; Hanker, Ariella; Wander, Seth Share Save
Tumor immune microenvironment modulates resistance to estrogen suppression in ER plus breast cancer Napolitano, Fabiana; Wang, Yunguan; Sudhan, Dhivya; Gonzalez-Ericsson, Paula; Formisano, Luigi; Guo, Lei; Chica-Parrado, M. Rosario; Lin, Chang-Ching; Lee, Kyung-Min; Ma, Hongli; Evans, Nathaniel; Servetto, Alberto; Mendiratta, Saurabh; Barnes, Spencer; Fang, Yisheng; Xu, Lin; Balko, Justin; Mills, Gordon; Labrie, Marilyne; Hanker, Ariella; Arteaga, Carlos Share Save
Proteogenomic approaches for the identification of NF1/neurofibromin-depleted estrogen receptor positive breast cancers for targeted treatment Kim, Beom-Jun; Zheng, Ze-Yi; Lei, Jonathan; Holt, Matthew; Chen, Anran; Peng, Jianheng; Fandino, Diana; Singh, Purba; Kennedy, Hilda; Dou, Yongchao; Chica-Parrado, M. Rosario; Bikorimana, Emmanuel; Ye, Dan; Wang, Yunguan; Hanker, Ariella; Mohamed, Nada; Hilsenbeck, Susan; Lim, Bora; Asirvatham, Jaya Ruth; Sreekumar, Arun; Zhang, Bing; Miles, George; Anurag, Meenakshi; Ellis, Matthew; Chang, Eric Share Save
ESR1 mutations drive resistance to CDK4/6 inhibitors in ER plus Breast Cancer Chica-Parrado, M. Rosario; Lin, Chang-Ching; Jaeger, Ellen; Harris, Michelle; Guo, Lei; Bikorimana, Emmanuel; Napolitano, Fabiana; Chao, Calvin; Hanker, Ariella; Arteaga, Carlos Share Save
Clinical and genomic landscape of ERBB2 and ERBB3 mutated breast cancer Bilani, Nadeem; Tao, Jacqueline; Safonov, Anton; Casey, Dana; Drago, Joshua; Ahmed, Mehnaj; Acevedo, Barbara; Jhaveri, Komal; Reis-Filho, Jorge; Robson, Mark; Toska, Eneda; Hanker, Ariella; Arteaga, Carlos; Chandarlapaty, Sarat; Wen, Hanna Y.; Razavi, Pedram Share Save
An FGFR1/2 degrader overcomes antiestrogen resistance in ER+/FGFR1-amplified breast cancer Uemoto, Yasuaki; Lin, Chang-Ching; Servetto, Alberto; Wang, Bingnan; Ye, Dan; Napolitano, Fabiana; Patel, Hima Milan; Formisano, Luigi; Chica-Parrado, M. Rosario; Bikorimana, Emmanuel; Mendiratta, Saurabh; Chen, Chuo; Hanker, Ariella; Arteaga, Carlos Share Save
ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate Cancer Xu, Yaru; Yang, Yuqiu; Wang, Zhaoning; Sjoestroem, Martin; Jiang, Yuyin; Tang, Yitao; Cheng, Siyuan; Deng, Su; Wang, Choushi; Gonzalez, Julisa; Johnson, Nickolas A.; Li, Xiang; Li, Xiaoling; Metang, Lauren A.; Mukherji, Atreyi; Xu, Quanhui; Tirado, Carla R.; Wainwright, Garrett; Yu, Xinzhe; Barnes, Spencer; Hofstad, Mia; Chen, Yu; Zhu, Hong; Hanker, Ariella B.; Raj, Ganesh V.; Zhu, Guanghui; He, Housheng H.; Wang, Zhao; Arteaga, Carlos L.; Liang, Han; Feng, Felix Y.; Wang, Yunguan; Wang, Tao; Mu, Ping Share Save
Share Save
Combined inhibition of CDK4/6 and AKT is highly active against the luminal androgen receptor (LAR) subtype of triple negative breast cancer (TNBC) Chica-Parrado, Rosario; Kim, Gun Min; Uemoto, Yasuaki; Ye, Dan; Napolitano, Fabiana; Lin, Chang-Ching; Bikorimana, Emmanuel; Lee, Kyung-Min; Mendiratta, Saurabh; Hanker, Ariella B.; Arteaga, Carlos L. Share Save
A selective FGFR1/2 degrader overcomes endocrine resistance in ER+/FGFR1amplified andFGFR1/2-mutant breast cancer Uemoto, Yasuaki; Lin, Chang-Ching; Wang, Bingnan; Ye, Dan; Bikorimana, Emmanuel; Servetto, Alberto; Formisano, Luigi; Napolitano, Fabiana; Parrado, Rosario Chica; Mendiratta, Saurabh; Chen, Chuo; Hanker, Ariella B.; Arteaga, Carlos L. Share Save
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER plus /RB-deficient breast cancer Lin, Chang-Ching; Chang, Tsung-Cheng; Wang, Yunguan; Guo, Lei; Gao, Yunpeng; Bikorimana, Emmanuel; Lemoff, Andrew; Fang, Yisheng V.; Zhang, He; Zhang, Yanfeng; Ye, Dan; Soria-Bretones, Isabel; Servetto, Alberto; Lee, Kyung-min; Luo, Xuemei; Otto, Joseph J.; Akamatsu, Hiroaki; Napolitano, Fabiana; Mani, Ram; Cescon, David W.; Xu, Lin; Xie, Yang; Mendell, Joshua T.; Hanker, Ariella B.; Arteaga, Carlos L. Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Not logged in.png){kind=icon}